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The wild-type -Phe*Pro- bond located at the N-terminus of the mature aspnrtic protcinasc of HIV-l was repluccd by -llc-Pro- or -V&Pro-. By 
this means, processing at this clcavngc junction was prevented and so. extended or precursor fcxs of HIV-protcinase were gcncmted. Thcsc 
constructs were expressed in ~xchcricl~iu cofi. purified therefrom, and their specificity. activity ut different pH values and susceptibility to the potent 
inhibitor, Ro3 l-8959, was assessed, A hitherto unobserved cleavage junction (at -Alu-Phe*Lcu-Gin-) in the frame-shift region of the gag-p01 
viral genome was identified and contirmcd by demonstrating clcnvagc of a synthetic pcptide corresponding to this region. The implications for 
viral replication of self-processing at neutral pH by proteinase whilst still present (in a prccuisur tjrm) as a component of the polyprotcin arc 
considered; such reactions, however, are still blocked cvcn at pH values us high us 8.0 by Ro3 l-8959. 
HIV-proteinase precursor; Activity and pH dcpcndcnce; Inhibition by Ro31-8959; Novel polyprotein clcuvagc junction 
1. INTRODUCTION (99 residue) HIV-l PR were engineered and their prop- 
erties were examined. 
Mammalian and fungal aspartic proteinases (PRs) 
are synthesized in the form of zymogens. Conversion to 
generate ach mature PR is frequently autocatalytic and 
requires the removal of a propart segment consisting of 
40-50 residues from the N-terminus of the molecules [l]. 
In the human immunodeficiency virus (HIV), synthesis 
of viral gag and pol proteins as the gag-pol polyprotcin 
necessitates cleavage to release the mature forms of each 
protein component. The dimeric aspartic PR encoded 
therein is responsible for these cleavages, including its 
own autocatalytic release [2]. The 65 residues (from the 
start of the pol orf) immediately upstream from the 
mature HIV-I PR (Fig. 1) have not as yet been ascribed 
a function but correspond to the prosegment found in 
the archerypal aspartic PR [33. Processing of the gag- 
pol polyprotein may be governed by the form in which 
its intrinsic PR is present, i.e. initially, at least, as a 
!arger precursor which may be different from ‘mature’ 
PR in terms of speciiicity, catalytic efficiency, pH de- 
pendence and, in turn, susceptibility to blockage by 
inhibitors designed against he mature PR. In order to 
study this, precursor or extended forms of the mature 
2. MATERIALS AND METHODS 
The BUIIIHI-EcoRV fragment of the BIHIO strain of HIV-1 cncod- 
ing the prosegment. PR. nnd the N-terminal region of reverse tran- 
scriplose wus uscrl in all constructs. In order to delinratc the PR 
components from reverse transcriptase. an in-frame stop codon wus 
introduced 31 the C-terminus of PR using the oligonucleotide. 
5’-AGTCTCAATAGGGCCiAATT’CAAAAAAI-l-TAAAGTGCA-3’. 
in conjunction wit:r the Oligonuclcotide-directed in vitro mutagenesis 
system (Amersham ~ntcmational. Bucks, UK). PCR mutagenesis by 
ovcrlup extension [4] was used to introduce the mutations. -lIc-Pro- 
or -Val-Pro- in place of the wild-type -Phc*Pro- clc3v3gc junction at 
the N-terminus of PR (Fig. !). Comparable reaulis wcrc derived for 
both mutations so, for brevity, only the data for the -Val-Pro- con- 
structs are described. The mutatcxl PR gene WBY subcloned into the 
following expression vectors; (i) pDS5B [S]; (ii) pDS56.6His [6] which 
encodes B His residues upstream from the N-terminus of the protein 
(construct WV in Fig. I); nnd (iii) pMAL Maltose-binding protein 
(MBP) fusion and purification system (New England Biolabs. Inc. 
Beverly. MA, USA) (construct Mv in Fig. 1). The corrcspondinp 
wild-type constructs were also enginL_red. Following all mutagenesis 
and reconstruction, each nuclcotidc sequence wz confn-mcd by didc- 
oxy sequencing. 
Correspordeme odckss: J. Kay, Department of Biochemistry, Uni- 
versity of Wales College of Cnrdiff, P.O. Box 903, CnrdilT CFI 1 ST, 
Wales, UK. Fax: (44) (222) 874 1 lb. 
E, cofi strain M 15 w;is used throughout for expression st udics [7]. 
Following induction with 1PTG (bctwcen 70 and 400 PpJml). culture 
aliquots wcrc removed after 2 h and anulyzcd by Wcs~ern blotting 
using a monoclonal antibody directed against the active site region of 
mature PR, as descrilxd previously [S]. 
..4bbrcvirdms: HIV, human immunodeficiency virus; PR, protcinase; 
MBP, multose-binding protein. The nomcncluture system ofSchcchter 
und Berger [Ii] i.e. P1-P,* P,‘-P2’ is usrd iu &pict itlllill0 acids 
adjacent to the residrus in the PI and PI’ positions which contribute 
to the scissile psptide bond (indicated by an asterisk*). 
For large-scale purification, the MBP-extended PR fusion (product 
of Mv in Fig. 1) was purified in a single step from lysntes of 500 ml 
M I5 cultures by affinity chromatogruphy on an amylose column as 
described in the manufacturer’s protocol. Autocatnlytic conversion of 
;hc pui-iiicd fiision protchi was aixd~zcd ii: 37’C in !c mM Tris-.HC! 
buffer, pH 8.0, containing 100 mM NaCI. or in the same bufl-er ad- 
justed to pll 5.0. G.0 or 7.0 by the addition of sodium phosphate 
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buff&s, as appropriate. Protein bands from SDS-gds were blotted 
directly onto PVDF membranes and loaded into an Applied Biosys- 
terns Al31 470A Scquenator for N-temlinnl sequence analysis by 
Edmnn degradation. The peptide, GSGDLAF*LQGKAR, was syn- 
the&cd by solid-phase methodologies and its hydrolysis was moni- 
tored by reverse-phase FPLC, as dcscribcd previously [9]. 
3. RESULTS AND DISCUSSION 
We have shown previously with synthetic peptide 
[9,10] and engineered protein [8] substrates that intro- 
duction of a b-branched amino acid into the P, position 
(nomenclature of Schechter and Berger [ 1 I]) prevents 
substrate cleavage by HIV PR. Consequently, to engi- 
neer an extended form of HIV PR that would not be 
capable of self-processing at its N-terminus to release 
mature PR, the N-terminal junction between the 
prosegment and PR was mutated from the wild-type 
-Phe*Pro- (Fig. 1) to -Ile-Pro- or -Val-Pro-. Upon ex- 
pression of these mutant constructs in E. cofi, a larger 
form of PR (A4, -18 kDa) was detected in the cell 
extracts by Western blotting (data not shown). Only low 
levels of the two extended PR accumulated, however. In 
order to generate larger amounts for further study and 
to facilitate purification by Ni-chelate chromatography 
[123, a fusion construct was made (H, in Fig. 1) in which 
6 histidine residues were positioned immediately up- 
.t 
stream From the start of the pok orf. Upon expression 
in E. cd, the equivalent wild-type -Phe*Pro- construct 
processed to release the anticipated mature (11 kDa) PR 
(Fig. 2) whereas the -Val-Pro- mutant construct gener- 
ated two bands of approx. 19 and 18 kDa when cell 
lysates were examined by SDS-PAGE and Western 
blotting (Fig. 2). The 19 kDa band had a comparable 
mobility to that of a distinct form of an extended HIV 
PR (Fig. 2, cf. lanes 2 and 3); this was produced by 
mutation of the active site Asp” residue (to Ala [ 13]), 
thus abolishing the autolytic processing ability to re- 
lease the prosegment from the mature 11 kDa pro- 
teinase. The 18 kDa band may have arisen by autocata- 
lytic clipping near the N-terminus of the extended PR 
molecules (see below). An identical result was obtained 
with the mutant containing -Be-Pro- (data not shown). 
There was, thus, no indication with these mutations of 
processing occurring at the N-terminus of mature PR 
to generate this 1 I kDa protein. The strategy of generat- 
ing -Ile-Pro- or -Val-Pro- sequences in place of the wild- 
type -Pbe*Pro- would appear, tilei:, to have been effec- 
tive in preventing autolytic cleavage at this junction. 
However, extensive attempts to extract and further pu- 
rify these forms of extended PR revealed that the histi- 
dine-tagged proteins were predominantly insoluble. 
Consequently, a further construct was engineered in 
which the -Val-Pro- mutant PR was placed as an in- 
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Fig. I. Extended HIV-1 yrotcinase constructs. The wild-type viral gug--PR sequence linking the C-terminus of gang with the N-terminus of PR in 
the pal region of the gcnome is detaikd irl tile top panel. The frame shift locirtion iu indicated by an arrow. In construct I-iv (middle pancij. the 
F*P bond at the N-terminus of mature PR was mutated to Y-P and a H6 tag was introduced in front of the extended PR molecules to facilitate 
amnity purification. In construct MY (bottom panel), a MBP domain was used instead. N-Terminal sequences that were determined (see text) are 
indicated in this construct by the bars. 
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Fig. 2. Characterization of the products derived from expression in 
I?. co/i of plnsmids harbouring Ha-tagged extended HIV-I PR. Con- 
struct Hv (see Fig. I) containing -V-P- at the N-terminus ofthe mature 
PR, is depicted in Ianc 2. Lanes 1 and 3 illnetmtc controls expressing 
the corresponding wild-type constructs with -F*P- at the N-terminal 
cleavage junction (lane I) and with mutation of the active site Asp 
residue PR to Ala (lane 3). Immunodetcction was carried OIJL using 
an anti-PR monoclonal antibody. Mol. wt. markers (kDa) migrated 
as indicated. 
frame fusion behind the soluble MBP (mol. wt. 42 kDa) 
linked through the sequence -IEGRISEF- to the start 
of the prosegment (construct Mv in Fig. 1). Following 
IPTG induction, two bands (at -60 and 18 kDa) on 
Western blots were stained with the anti-PR monoclo- 
nal antibody, whereas only the 60 kDa band reacted 
with antibody to MBP. The upper band corresponded 
in size to that anticipated for the fusion between MBP 
and extended DR. Reasonable quantities (10 mg!l) of 
soluble product were generated in ,Z. co/i and further 
purification was accompiishcd by affinity chromatogra- 
phy on an amylosc-agarose column. The material re- 
tained by the amylose resin displayed the same two 60 
kDa and 18 kDa bands on SDS-PAGE (Fig. 3), as had 
been observed in the cell lysates. The 18 kDa band was 
eluted from a preparative SDS-gel and Edman degrada- 
tion indicated it to have the N-terminal sequence, 
LQGKAREFSSEQT- (see Fig. 1, bottom). Since af- 
finity chromztography on amylose resin requires the 
presence of a MBP component, the presence of this 18 
kDa band in the puriiied material is most readily ex- 
plained by the formation of heterodimeric molecules 
through association of one subunit consisting of full- 
length MBP-extended PR with another comprising ex- 
tended PR but devoid of MBP. The formation of such 
a heterodimeric structure suggests that the protein must 
have been folded correctly in order to achieve dimeriza- 
tion. 
The column-purified material was dialysed against 10 
mM Tris-HCl buffer, 100 mM NnCl, pH 8.0 and then 
incubated in this buffer at 37OC. The fusion protein 
disappeared, as monitored both by the antiserum to 
MBP and the anti-PR monoclonal (Fig. 4, left panels, 
upper and lower, I,espectively) with generation of free 
MBP (at p-42 kDa). This conv,srsion was slow initially 
(within the first 24 L-I) but accelerated thereafter (to be 
complete between 24 and 30 h), reminiscem of an au- 
tocatalytic reaction. A parallel incubation was thus per- 
formed in the presence of 100 nM Ro31-8959, an inhib- 
itor that is completely specific for HlV PR [14]. No 
conversion occurred under these conditions (Fig. 4, 
right panels), confirming that an autocatalytic leavage 
is indeed responsible. When the fate of the 18 kDa 
extended PR was monitored, this band disappeared 
(Fig. 4, bottom left panel). Two new bands (of around 
14 and 13 kDa) were generated that were immunoreac- 
tive with the anti-PR antibody. The upper of these (at 
-14 kDa) was cluted from a preparative SDS-gel and 
subjected to N-terminal sequencing. The sequence 
began EQTRANSPTI- (Fig. 1, bottom). After incuba- 
tion for 30 h and longer, no immunoreactive PR species 
could be detected (Fig. 4, bottom left panel). This au- 
tolytic destruction was prevented by inclusion of Ro31- 
9959 (Fig. 4, bottcm right panel). 
A further set of incubations was then performed at 
pH 5.0, 6.0, 7.0 and 8.0, and the extent of conversion 
was assessed by SDS-PAGE and silver staining. No 
autolytic release of the MBP from the fusion protein 
was observed at ~1-15.0 (Fig. S), whereas conversion did 
occur at all the higher pM values. This implies that the 
extended HIV- 1 PR does not require an acidic environ- 
ment to be active. This is in contrast with the mature 
form of the enzyme which is maximally active at pH 
values of 5.0 and below [9]. 
From these data, it is apparent hat the extended or 
precursor forms of HIV PR have intrinsic activity which 
can be directed in an autolytic fashion to ensure self- 
processing. Mature HIV PR is capable of hydrolysing 
two types of cleavage junction I-Aromatic*Pro- and 
-Hydrophobic*Hydrophobic- bonds [lS]) and many 
18 - - 
1 2 3 4 5 
Fig. 3. SDS-PAGE of protein purified by affmity chromatography of 
the soluble extract from E. cwli harbouring the plasmid containing the 
MBP-extended HIV-I PR fusion. Aftcrantrifuugtion. soluble lysatcs 
wcrc npplicd to a column of amylose-a&arose in 10 mM sodium 
phosphate buff&, pH 7.0 containing 0.5 M NaCI, 10 mM mcrcxp- 
toethanol and 1 mM EGTA. After extensive washing, desorption was 
achieved using the same buffer containing IO mM maltox. Aliquow 
of this dcsorbed material were enalyzcd by SDS-PAGE and visunlized 
by staining with Coomilssic blue (lane 2) or, in Western blots. by 
immunnstaining with an antiserum to MBP [lnnc4) or with an and-PR 
monoclonal antibody (lane 5). Samples of authentic MBP [supplied 
by New England Biolabs. Inc.) were stained with Coomassic bluc(lane 
I) or with :hc antiserum to MBP (lane 3). 
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previous investigations by us and by others [9,10,16] 
have revealed that, for the latter, the sequence -Ile/Val/ 
Ala-Hydrophobic*Hydrophobic.Glu/Gln- is optimal. 
The sequence -Ala-Phe*Leu-Gln. found at the N-termi- 
nal end of our constructs (Fig. 1) matches this consensus 
pattern, and its position, immediately downstream from 
the gag-pol frame shift region of the viral genome (indi- 
cated by the arrow in Fig. 1), would suggest another 
cleavage junction, hitherto unobserved, in this location 
in the viral polyprotein. In order to test this assertion 
further, a synthetic peptide (GSGDLAF*LQGKAR) ,  
spanning this putative cleavage site and corresponding 
to the sequence in our Hv and Mv constructs, was inca- 
bated with homogeneous mature H1V-I PR under iden- 
tical conditions (at pH 4.7) to those we have described 
previously for other synthetic peptide substrates [9,10]. 
Complete cleavage to generate two products was ob- 
served; these were seperated by reverse-phase FPLC 
and their amino acid compositions were determined. 
These were Asp 1.0, Set 0.9, Gly 2.2, Ala 1.1, Leu 1.1, 
Phe 1.1, and Glu 1.1, Gly 1.0, Ala 1.0, Leu 1.0, Lys 1.0, 
Arc I.i, respectively, confirnaing that cleavage had in- 
deed taken place at the projected -Phe*Leu- bond. Val- 
ues of 680 #M and 2 s-' were determined, respectively, 
for the kinetic parameters, Km and k~,, for the hydroly. 
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sis of this peptide. These are comparable to the values 
obtained previously with other peptide substrates tbr 
HIV-I PR containing Ala and Gin in P2 and P2', respec- 
tively [10,15,16]. Thus, it would appear that an addi- 
tional cleavage junction may well be present in the gag- 
pol polyprotein of HIV-1. Hydrolysis at this location 
would ensure that gag molecules were 'disconnected' 
fi'om the encumbrance of a pol tail despite the frame 
shift; and in the downstream direction, with cleavage 
also occurring in the wild-type genomic product at the 
N-terminus (Phe*Pro) of the mature PR (Fig. 1, top 
line), a peptide of approx. 65 residues should be re- 
leased. Indeed, a component of just such a size has been 
visualized (by an antibody which recognizes this seg- 
ment) in virion extracts (S.F.J. Le Grice, personal com- 
munication) bat its functional significance remains to be 
elucidated. 
The other implication which arises from this study is 
that the extended or precursor forms of HIV PR (albeit 
in the form of  a heterodimer with one subunit attached 
to MBP) may not require acidic conditions for activity. 
Considerable thought (see e.g. in [17]) has been given as 
to how the developing I-IIV virion may become acidified 
in order to accomplish its essential proteolytic proces- 
sing. But acidification may not be necessary; if the char- 
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Fig. 5. pH dependence of the self-processing of the MBP-extended HIV-I PR. The affinity-purified products from expre~ion ofeonstruet My in 
E. coil were incubated at pH 5.0 or 6.0 (upper panels, left and right, respectively) and pH 7.0 or 8.0 (lower panels, lel't and fight, respectively). 
Samples were removed at the indicated tim¢~ and analyzed by SDS-PAGE followed by silver staining. The absence o1" processing at pit 5.0 is 
illustrated from the increased loading of material in the 48 h sample. Samples of authentic MBP are included as marker5 in all panels. 
aeteristics of the fusion protein (an artificial construct 
for ease of manipulation) studied herein should be re- 
flected in the wild-type gag-PR-poi polyprotein fusion, 
then the precursor form(s) with PR still present as a 
component in the polyprotein, may be capable of per- 
forming the requisite cleavages at neutral pH. At the 
same time, this processing would result in the release of 
the mature form of PR itself, which would be dormant 
under the neutral pH conditions of the infected cell. 
This may be advantageous to viral replication overall 
since the PR would be less able to attack host cell pro- 
teins and thus incapacitate the host cell; under acidic 
conditions, PR does digest cellular proteins e.g. [18- 20]. 
Clearly, further investigations are necessary to exam- 
ine this concept in more detail, and experiments are 
under way to purify sufficient quantities of the extended 
forms of PR to permit comparison of their kinetic para- 
meters at different pH values with tho~e ~etermined 
previously [9,10] for the mature form of H1V-1 PR. 
However, it is evident from Fig. 4~ that, irrespective of 
the precise nature of the form of the PR tha~ is respon- 
sible for polyprotein processing and the pH at which 
this takes place, the inhibitor, Ro31-8959, is effective in 
blocking proteolysis even at pH values as laigia as 8.0. 
Thi~ compound is currently undergoing clinical trials in 
Italy, France and the UK for the treatment of AIDS; 
their outcome is thus being awaited with justifiable in- 
terest. 
A cknou'ledgements: This work was supported by the AIDS-Directed 
Programme of the Medical Re,earth Council and by NIH Grant Ai 
28571. We are very grateful to Ray .lupp, Stuart Le Griee and Jo- 
nathan T. Griftiths lbr contributing their enthusiasm and valuable 
advice, and particularly to Dr. Carol Carter, Stony Brook, for many 
exciting discussions and for sharing with us her own results in this aeea 
prior to publication. 
REFERENCES 
[ll Kay, J. (1985) in: A~partic Proteina~5 and Their lahibitors 
(Kostka, V. ed.) pp. l-IS, Waiter de Gruyter, Berlin. 
[2] Kay, J. and Dunn, B.M. (1990) Bioehim. Biophys. Aeta 1048, 
!-18. 
[3] Partin, K., Zybarth, G., Ehrlieh, L., De Crombrugghe, M., Wim- 
mer, E. and Carter, C. (1991) Proc. Natl. Aead. Sci. USA 88, 
4776~780. 
[4] Ho, S.N., Hunt, H.D., Horton, R.M., Pollen, J.K. and Pea~. 
L.R. (1989) Gene 77, 51-59. 
[5] Stnber, D., lbrahimi, L., Cutler, D., Dobberstein, B. and Bujard, 
H. (1984) EMBO J. 3, 3143-3148. 
[6] Bujard, J., Gcntz, R., Lanzer, M., St~ber, D., Mudler, M., 
lbrahimi, !., Haeuptle, M.T. and Dobber~tein, B. (1987) Methods 
Enzymol. 155. 416--433. 
[7] Certa, U., Bannwarih, W., Slueber, D., Genie, R., Laazer, M., 
L¢ Griee, S.F.J., Galliot, F., Wendler, I., Hunsmann, G., Bujard, 
H. and Mous, .I. (1986) EMBO J. 5, 680-685. 
453 
Volume 314, number 3 FEBS LETTERS De¢0mber 1992 
[8] Jupp, R.A., Phylip, L.H., Mills, J.S., Le Grice, S.F.J. and Kay, 
J. (1991) FEBS Lett. 283, 180-184. 
[9] Richards, A.D., Phylip, L.H., Farmerie, W.G., Searborough, 
P.E., Alvarez, A., Dunn, B.M., Hirel, Ph.-H., Konvalinka, J., 
Strop, P., Pavlickova, L., Kostka, V. and Kay, J. (1990) J. Biol. 
Chem. 265, 7733-7736. 
[10] Phylip, LH., Riehards, A.D., Kay, J., Konvaiinka, J., Strop, P., 
Kostka, V., Ritchic, AJ., Broadhurst, A.V., Farmcrie, W.G., 
Searboroa~h, P.E. and Dunn, B.M. (1990) Bioehem. Biophys. 
Res. Comman. 171,439--444. 
[11] Schgehter, I. and Berger, A. (1967) Bioehim. Biophys. Res. Com- 
mun. 27, 157-162. 
[12] ltochuli. E., Bannwarth, W., Dubeli, H., Gentz, R. and Stfiber, 
D. (1988) Biotedmology 6, 1321-1325. 
[13] Le Griee, S.FJ., Mills, J.S. and Mous, J. (1988) EMBO J. 7, 
:2547-2553. 
[14] Roberts, N.A., Martin, J.A., Kinchington, D., Broadhurst, A.V., 
Craig, J.C., Duncan, I.B., Galpin, S.A., Handa. B.K., Kay, J., 
Krohn, A., Lambert, R.W., Merrett, J.H., Mills, J.S., Parkes, 
K.E.B., Rcdshaw, S., Ritchie, A.J., Taylor, D.L., Thomas, G.L. 
and Machin, P.J. (1990) Science 248, 358-361. 
[15] Griffiths, J.T., Phylip, L.H., Konvalinka, J., Strop, P., Gustchi- 
ha, A., Wlodawer, A., Davenport, R.J., Bri~Bs, R., Duma, B.M. 
and Kay, .I. (1992) Biochemistry 31, 5193-5200. 
[16] Poorman, R.A., Tomasselli, A.G., Heinrikson, R.L. and Kezdy, 
FJ. (1991) J. Biol. chem. 266, 14554--14561. 
[17] Pearl, L.H. (1990) Retroviral Proteases: Maturation and Mor- 
phogenesis, pp. 1-180, Macmillan Pres~, London. 
[18] Wallin, M., Delnum, J., Goober, L. and Danielson, U.H. (1990) 
J. Gen. Virol. 71, 1985-1991. 
[19] Tomas~elli, A.G., Hut, J.O., Adams, L., Chosay, J., Lowery, D., 
Greenber 8, B., Yem, A.. Deibel, M.R., Zureher-Neely, H. and 
Heinrikson, R.L. (1991) J. Biol. Chem. 266, 14548-14553. 
[20] Honer, B., Shoeman, R.L. and Traub, P. (1992) Cell Biol. Int. 
Rep. 16, 603-612. 
454 
